Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 2, 2009, Pages 187-191

  Badawy, Ahmed ^a   Shokeir, Tarek ^a   Allam, Abdel Fattah ^a   Abdelhady, Hesham ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Aromatase inhibitors; Clomiphene citrate; Pregnancy outcome

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; LETROZOLE; CLOMIFENE; FERTILITY PROMOTING AGENT; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; CONGENITAL HEART DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; OVULATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; FEMALE INFERTILITY; NEWBORN; OVULATION INDUCTION; PREGNANCY;

ABORTION, SPONTANEOUS; ADULT; AROMATASE INHIBITORS; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; NITRILES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; TRIAZOLES;

EID: 59649128292     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340802638199     Document Type: Article

References (21)

1. Mitwally M, Casper R. Use of aromatase inhibitor for ovulation induction in patients with an inadequate response to clomiphene citrate. Fertil Steril. 2001;75:305-9.
2. Bayar U, Tanriverdi HA, Aykut B, Ayoǧlu F, .Özcan O, Erdal K. Letrozole vs. clomiphene citrate in patients with ovulatory infertility. Fertil Steril. 2006;85:1045-8.
3. Al-Fozan H, Al-Khadouri M, Tang SL, Tulandi T. A randomized trial of letrozole versus clomiphene citrate in women undergoing superovulation. Fertil Steril. 2004;82:1561-3.
4. Mitwally M, Casper R. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril. 2002;77:776-80.
5. Healey S, Tan SL, Tulandi T, Biljan M. Effects of letrozole on superovulation with gonadotropins in women undergoing intrauterine insemination. Fertil Steril. 2003;80:1325-9.
6. Byung CJ, Seung YK, Chang SS, Ki CK, Won DL. Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril. 2006;85:1774-7.
7. Biljan MM, Hemmings R, Brassard N. The outcome of 150 babies following the treatment with letrozole or letrozole and gonadotropins. Fertil Steril. 2005;84(supp. 1):O-231, Abstract 1033.
8. Gonen Y, Casper RF. Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod. 1990;5:670-4.
9. Yagel S, Ben-Chetrit A, Anteby E, Zacut D, Hochner-Celnikier D, Ron M. The effect of ethinyl estradiol on endometrial thickness and uterine volume during ovulation induction by clomiphene citrate. Fertil Steril. 1992;57:33-6.
10. Dickey RP, Olar TT, Taylor SN, Curole DN, Matulich EM. Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril. 1993;59:756-60.
11. Badawy A, Abdel All I, Abu Elatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome? A prospective randomized trial. Fertility & Sterility Online. 19 June 2007 (2007.02.062).
12. Badawy A, Abdel All I Abu Elatta M. Clomiphene citrate or anastrozole for ovulation induction in women with polycystic ovarian syndrome? A prospective controlled trial. Fertil Steril. 2007 (In press).
13. Varma TR, Patel RH, Bhathenia RK. Outcome of pregnancy after infertility. Acta Obstet Gynecol Scand. 1988;67:115-9.
14. Hill GA, Bryan S, Herbert CM 3rd, Shah DM, Wentz AC. Complications of pregnancy in infertile couples: routine treatment versus assisted reproduction. Obstet Gynecol. 1990;75:790-4.
15. Fontana PG, Leclerc JM. Contraindication of Femara® (letrozole) in premenopausal women. http://www.ca.novartis. com/downloads/en/letters/femara- hcp-e-17-11 05.pdf.
16. Luthra R, Kirma N, Jones J, Tekmal RR. Use of letrozole as a chemopreventive agent in aromatase overexpressing transgenic mice. J Steroid Biochem Mol Biol. 2003;86:461-7.
17. Mitwally M, Biljan M, Casper R. Pregnancy outcome after the use of an aromatase inhibitor for ovarian stimulation. Am J Obstet Gynecol. 2005;192:381-6.
18. Tulandi T, Martin J, Al-Fadhli R, Kabli N, Forman R, Hitkari J, et al. Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fetil Steril. 2006;85:1761-5.
19. Bishai R, Arbour L, Lyons C, Koren G. Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. Teratology. 1999;60:143-5.
20. Physicians Desk Reference PDR. 55th ed. Anastrozole. Montvale, NJ: Medical Economics Company Inc.; 2001. p. 662-85.
21. Hu Y, Cortvrindt R, Smitz J. Effects of aromatase inhibition on in vitro follicle and oocyte development analyzed by early preantral mouse follicle culture. Mol Reprod Dev. 2002;61:549-59.